Caricamento...
Editorial focus: understanding off-target effects as the key to successful RNAi therapy
With the first RNA interference (RNAi) drug (ONPATTRO (patisiran)) on the market, we witness the RNAi therapy field reaching a critical turning point, when further improvements in drug candidate design and delivery pipelines should enable fast delivery of novel life changing treatments to patients....
Salvato in:
| Pubblicato in: | Cell Mol Biol Lett |
|---|---|
| Autori principali: | , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
BioMed Central
2019
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6902517/ https://ncbi.nlm.nih.gov/pubmed/31867046 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s11658-019-0196-3 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|